Clarification regarding press release about CE marking

With reference to yesterday's press release, where we informed that we have filed TK 210 ELISA for CE mark registration at the Medical Products Agency (LMV), we would like to make a clarification. LMV does not approve products for CE mark but register the manufacturer and product as filed for CE marking. The product can then be marketed as CE marked. The processing time for this registration by LMV is usually 2-3 weeks.

For additional information please contact:
Jan Stålemark, CEO

AroCell AB (publ)

Tel: +46706-926206

About AroCell

AroCell AB (publ) is a Swedish company that develops standardized modern blood tests to support the prognosis and follow up of cancer patients. AroCell's new technologies are based on patented methods to measure TK1 protein levels, which provide valuable information about the speed of cell turnover. A tumor has high cell turnover and as a result TK1 can be detected in the blood with a standard laboratory test, called TK 210 ELISA. The test provides valuable clinical information for prognosis and optimization of treatment strategy. The test may also be used for monitoring disease relapse. For more information, please see AroCell is listed at AktieTorget and has about 1 650 shareholders.